Select Page

1st-of-its kind study unearths factors radiology providers can modify to boost cancer screening uptake
“A first-of-its kind new study examines factors radiology providers can modify to boost screening uptake. Challenges addressing lung cancer are well-documented: Only 5% to 21% of eligible Americans undergo low-dose CT imaging. These numbers are even worse among populations that bear a disproportionate burden of lung cancer, experts detailed in JAMA Network Open [1]. Black individuals, for instance, are 16% less likely to survive five years after a diagnosis, with worse odds of receiving LDCT.”

Dr. Eric Singhi on Why It’s Critical to Bring Practice-Changing Lung Cancer Developments to Community Oncologists
“Advancements in Oncology, held on Saturday, June 1, featured key insights on new lung cancer data presented at the annual meeting, in addition to panels on breast, gastrointestinal, and genitourinary cancers. The event focused on providing key updates for community oncologists, which was particularly important in the lung cancer setting, with multiple practice-changing updates being presented.”

Stress Related to Residing in Violent Neighborhoods May Be Tied to Aggressive Lung Cancer in Black Men
“Exposure to increased neighborhood violence may change the glucocorticoid receptor for the stress hormone cortisol and influence the aggressiveness of lung cancer, according to new findings presented by Heath et al at the Endocrine Society’s Annual Meeting & Exposition 2024.”

AI Blood Test Dependably Detects Lung Cancer
“Using artificial intelligence technology to identify patterns of DNA fragments associated with lung cancer, researchers from the Johns Hopkins Kimmel Cancer Center and other institutions have developed and validated a liquid biopsy that may help identify lung cancer earlier. In a prospective study published June 3 in Cancer Discovery, the team demonstrated that artificial intelligence technology could identify people more likely to have lung cancer based on DNA fragment patterns in the blood.”

Lung Cancer Screening Before and After a Multifaceted Electronic Health Record Intervention
“Question  Is a multifaceted lung cancer screening intervention, including a shared decision-making tool, clinician-facing reminders, narrative guidance provided in the ordering process, and patient-facing reminders, associated with improved screening-related care (care gap closure) for lung cancer screening?”

Positive results in lung cancer show benefits of subcutaneous bispecifics
“Key takeaways: Subcutaneous delivery reduced administration time from several hours to less than 5 minutes. Although unexpected, researchers reported improvement in PFS and OS with subcutaneous delivery.”

Long-term Data in Patients with Metastatic Non-Small Cell Lung Cancer Harboring MET Exon 14 Skipping Alterations
“TEPMETKO recently received full approval from the FDA for the above indication.2 The conversion to full FDA approval was based on data from the pre-planned confirmatory long-term follow-up analysis of Cohort C of the VISION study. TEPMETKO is the only FDA-approved once-daily oral MET inhibitor and may be dose-reduced in order to help manage adverse reactions.”

ASCO: Ivonescimab Improves Progression-Free Survival in EGFR+ Lung Cancer
“THURSDAY, June 6, 2024 (HealthDay News) — For patients with non-small cell lung cancer with the epidermal growth factor receptor (EGFR) variant, ivonescimab plus chemotherapy improves progression-free survival, according to a study published online May 31 in the Journal of the American Medical Association to coincide with the annual meeting of the American Society of Clinical Oncology, held from May 31 to June 4 in Chicago.”

Addabbo Bill Requiring Health Insurance Coverage For Lung Cancer and Breast Cancer Screening Approved by NYS Senate
“Queens, NY (June 6, 2024): New York State Senator Joseph P. Addabbo, Jr. announced his bill (S.8553C) requiring health insurance policies to provide coverage, without a co-pay or deductible for lung cancer screening, was approved by the New York State Senate.”

Lung cancer screening found to prolong lives in real-world study
“Among US veterans diagnosed with lung cancer through the Veterans Health Administration health care system, those who underwent screening before diagnosis were more likely to be diagnosed with earlier stage disease and had a higher cure rate than those who had not been screened.”

New Study Finds Most Eligible U.S. Adults not Getting Screened for Lung Cancer
“ATLANTA, June 10, 2024 — A new study led by American Cancer Society (ACS) researchers shows less than one-in-five eligible individuals in the United States were up-to-date (UTD) with recommended lung cancer screening (LCS). The screening uptake was much lower in persons without health insurance or usual source of care and in Southern states with the highest lung cancer burden. The findings are published today in JAMA (Journal of the American Medical Association) Internal Medicine.”